Sweden · Biotechnology startup
Sweden · Sigrid Therapeutics
Sigrid Therapeutics is developing an ingested medical device for lowering blood sugar in prediabetics.
Funding reportedLast round: Undisclosed round
What company datasets say Sigrid Therapeutics raised
Funding, as reported
Reported in all32.5Min the source's currency
Rounds6
Last roundUndisclosed round
Last round dateOct 2023
Investors listed9
Founders and team
From Sigrid Therapeutics's own website: 1 founder, 4 on the team.
Prof. Tore BengtssonChief Scientific Officer & Founder
- Claus KjærsgaardChief Executive Officer
- Kasper WickzénChief Commercial Officer
- Johnny SommarlundBoard Member
- Ulf WiinbergBoard Member
Biotechnology in Sweden
Startups like it
Is this your company?
Add your raise, your deck and your story, and put Sigrid Therapeutics in front of investors. Or tell us what we have wrong.